Altered peripheral amino acid profile indicate a systemic impact of active celiac disease and a possible role of amino acids in disease pathogenesis

PLoS One. 2018 Mar 14;13(3):e0193764. doi: 10.1371/journal.pone.0193764. eCollection 2018.

Abstract

Background: We have previously performed a Genome Wide Association and linkage study that indicated a new disease triggering mechanism involving amino acid metabolism and nutrient sensing signaling pathways.

Objective: The aim of this study was to investigate if plasma amino acid levels differed among children with celiac disease compared with disease controls.

Materials and methods: Fasting plasma samples from 141 children with celiac disease and 129 non-celiac disease controls, were analyzed for amino acid levels by liquid chromatography-tandem mass spectrometry (LC/MS). A general linear model using age and experimental effects as covariates was used to compare amino acid levels between children with a diagnosis of celiac disease and controls.

Results: Seven out of twenty-three analyzed amino acids were elevated in children with celiac disease compared with controls (tryptophan, taurine, glutamic acid, proline, ornithine, alanine and methionine). The significance of the individual amino acids do not survive multiple correction, however, multivariate analyses of the amino acid profile showed significantly altered amino acid levels in children with celiac disease overall and after correction for age, sex and experimental effects (p = 8.4 × 10-8).

Conclusion: These findings support the idea that amino acids could influence systemic inflammation and play a possible role in disease pathogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Age Factors
  • Amino Acids / blood*
  • Biomarkers / blood
  • Celiac Disease / blood*
  • Child
  • Child, Preschool
  • Chromatography, Liquid
  • Fasting
  • Female
  • Humans
  • Infant
  • Linear Models
  • Male
  • Multivariate Analysis
  • Tandem Mass Spectrometry

Substances

  • Amino Acids
  • Biomarkers

Grants and funding

The corresponding author of this paper, Dr. Åsa Torinsson Naluai, received funding from the following organizations: Magnus Bergvalls Stiftelse, Svenska Läkaresällskapet, Bengt Ihres stiftelse, Rut och Richard Julins stiftelse, Tore Nilsons Stiftelse för Medicinsk Forskning, Stiftelsen Apotekare Hedbergs Fond, and The Swedish Coeliac Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.